Immature (undifferentiated) cells are on the left panel and cells that have differentiated in response to treatment with brequinar are on the right panel. Photo courtesy of Scadden Lab.

Simple compound could provide first new therapy for AML in...

Zika virus (light blue) spreads through a three-dimensional model of a developing brain. Image courtesy of Max Salick and Nathaniel Kirkpatrick/Novartis

The fast-spreading virus can take multiple routes into developing human nerve cells....

HSCI codirector David Scadden has been named a Fellow of the American Association for the Advancement of Science (AAAS). 

This year 391 members have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to advance science or its applications. New...

Photo courtesy of Vionnie Yu, Scadden Lab. 

Color-labeling helps Harvard researchers track the development and behavior of individual cells

By Hannah Robbins

Harvard...

Startup Magenta Therapeutics licences technologies from Harvard, MGH, and Boston Children's that could transform treatment of blood diseases and immune disorders

Harvard University has completed a license agreement with Magenta Therapeutics, a new startup company launched in Cambridge, for a portfolio of technologies with the potential to transform blood stem cell transplants from a “treatment of last resort” into a safer, more efficient therapy for patients with blood diseases...

The Harvard Stem Cell Institute (HSCI) is pleased to announce the success of the 2015–16 General Fund Matching Challenge. Throughout fiscal year 2016, HSCI saw an outpouring of unrestricted funding, resulting in $2.6 million in new gifts and pledges. This support...

Tongue-on-a-chip provides insight into genetic diseases

By Leah Burrows, SEAS Science and Technology Communications Officer

Muscular dystrophy is a group of rare genetic diseases that cause progressive muscle weakness and deterioration. For decades, researchers...

In a flask of clear, pale yellow liquid, 300-400 million beta cells, the insulin-producing cells attacked or defective in diabetics, swirl in a cocktail of cell food and Stage 6 medium. Ten years ago, researchers were still working on protocols to...

Harvard Stem Cell Institute is pleased to announce four of our Principal Faculty members have been named Howard Hughes Medical Institute (HHMI) Faculty Scholars.  Fernando Camargo, Benjamin Ebert, Jayaraj Rajagopal, and John Rinn are among the...

Alex Schier is the author of a recent study on the use of CRISPR to mark cells with a genetic barcode that can be used to track the development of cells and reconstruct their lineages. Photo...

Young neurons (pink), responsible for encoding new memories, must compete with mature neurons (green) to survive and integrate into the hippocampal circuit. Photo courtesy of Kathleen McAvoy, Sahay Lab.

CALL FOR PROPOSALS

CANCER PROGRAM PILOT GRANTS 2017 

The Cancer Program of the Harvard Stem Cell Institute (HSCI) invites applications for pilot grants to be awarded for research in 2017. The intent is to provide resources for innovative projects in cancer stem cell biology, including basic and translational research. This funding is for innovative, high-impact research projects that will fundamentally advance current understanding of...